Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Flemmig, C."'
Autor:
Forchhammer S; Department of Dermatology, Eberhard Karls University of Tuebingen, Liebermeisterstrasse 25, 72076, Tuebingen, Germany. stephan.forchhammer@med.uni-tuebingen.de., Pop OT; Institute for Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland., Hahn M; Department of Dermatology, Eberhard Karls University of Tuebingen, Liebermeisterstrasse 25, 72076, Tuebingen, Germany., Aebischer V; Department of Dermatology, Eberhard Karls University of Tuebingen, Liebermeisterstrasse 25, 72076, Tuebingen, Germany., Seitz CM; Pediatric Hematology and Oncology, Children's Hospital, Eberhard Karls University of Tuebingen, Tuebingen, Germany., Schroeder C; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University of Tuebingen, Tuebingen, Germany., Liebmann A; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University of Tuebingen, Tuebingen, Germany., Abele M; Pediatric Hematology and Oncology, Children's Hospital, Eberhard Karls University of Tuebingen, Tuebingen, Germany., Wild H; Pediatric Hematology and Oncology, Children's Hospital, Eberhard Karls University of Tuebingen, Tuebingen, Germany., Bien E; Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk, Gdansk, Poland., Kunc M; Department of Pathomorphology, Medical University of Gdansk, Gdansk, Poland., Schneider DT; Clinic of Pediatrics, Dortmund Municipal Hospital, University Witten/Herdecke, Dortmund, Germany., Cuk K; BioNTech SE, Mainz, Germany., Büttel I; BioNTech SE, Mainz, Germany., Flemmig C; BioNTech SE, Mainz, Germany., Peters M; BioNTech SE, Mainz, Germany., Laible M; BioNTech SE, Mainz, Germany., Brück P; BioNTech SE, Mainz, Germany., Türeci Ö; BioNTech SE, Mainz, Germany., Sahin U; BioNTech SE, Mainz, Germany., Flatz L; Department of Dermatology, Eberhard Karls University of Tuebingen, Liebermeisterstrasse 25, 72076, Tuebingen, Germany.; Institute for Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.; Department of Dermatology, Venereology, and Allergology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Brecht IB; Pediatric Hematology and Oncology, Children's Hospital, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
Publikováno v:
Virchows Archiv : an international journal of pathology [Virchows Arch] 2024 Aug; Vol. 485 (2), pp. 335-346. Date of Electronic Publication: 2024 Jun 18.
Autor:
Mackensen A; University Hospital Erlangen, Department of Internal Medicine 5, Hematology/Oncology, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Haanen JBAG; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands.; Leiden University Medical Center, Department of Oncology, Leiden, the Netherlands., Koenecke C; Hannover Medical School, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany., Alsdorf W; University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Hamburg, Germany., Wagner-Drouet E; University Medical Center Mainz, 3rd Medical Department, Hematology and Oncology, Mainz, Germany., Borchmann P; University Hospital of Cologne, Department I of Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Heudobler D; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.; University Hospital Regensburg, Department of Internal Medicine III, Hematology and Oncology, Regensburg, Germany., Ferstl B; University Hospital Erlangen, Department of Internal Medicine 5, Hematology/Oncology, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Klobuch S; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands., Bokemeyer C; University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Hamburg, Germany., Desuki A; University Medical Center Mainz, 3rd Medical Department, Hematology and Oncology, Mainz, Germany., Lüke F; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.; University Hospital Regensburg, Department of Internal Medicine III, Hematology and Oncology, Regensburg, Germany., Kutsch N; University Hospital of Cologne, Department I of Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Müller F; University Hospital Erlangen, Department of Internal Medicine 5, Hematology/Oncology, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Smit E; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands., Hillemanns P; Hannover Medical School, Department of Gynecology and Obstetrics, Hannover, Germany., Karagiannis P; University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Hamburg, Germany., Wiegert E; Bexon Clinical Consulting, Upper Montclair, NJ, USA., He Y; BioNTech SE, Mainz, Germany., Ho T; BioNTech US, Cambridge, MA, USA., Kang-Fortner Q; BioNTech US, Cambridge, MA, USA., Schlitter AM; BioNTech SE, Mainz, Germany., Schulz-Eying C; BioNTech SE, Mainz, Germany., Finlayson A; BioNTech SE, Mainz, Germany., Flemmig C; BioNTech SE, Mainz, Germany., Kühlcke K; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany., Preußner L; BioNTech SE, Mainz, Germany., Rengstl B; BioNTech SE, Mainz, Germany.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Türeci Ö; BioNTech SE, Mainz, Germany.; BioNTech US, Cambridge, MA, USA.; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Şahin U; BioNTech SE, Mainz, Germany. Ugur.Sahin@biontech.de.; BioNTech US, Cambridge, MA, USA. Ugur.Sahin@biontech.de.; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany. Ugur.Sahin@biontech.de.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany. Ugur.Sahin@biontech.de.
Publikováno v:
Nature medicine [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2844-2853. Date of Electronic Publication: 2023 Oct 23.
Publikováno v:
Children, Vol 7, Iss 198, p 198 (2020)
Children
Children
Adverse thromboembolic events following administration of the anti-fibrinolytic agent tranexamic acid (TA), used to prevent/treat excessive blood loss, are rare. We present the clinical course of two young patients (22 and 56 months) receiving busulf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6416dda6994a25d01a8c93c9d0ddd396
Autor:
Mackensen, A., Haanen, J.B.A.G., Koenecke, C., Alsdorf, W., Wagner-Drouet, E., Heudobler, D., Borchmann, P., Bokemeyer, C., Klobuch, S., Smit, E., Müller, F., Desuki, A., Lüke, F., Wiegert, E., Flemmig, C., Schulz-Eying, C., Rengstl, B., Preussner, L., Türeci, Ö., Sahin, U.
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S1404-S1405
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zirngibl F; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.; Berliner Institut für Gesundheitsforschung (BIH), 10178 Berlin, Germany., Flemmig C; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.; Parexel International GmbH, 14050 Berlin, Germany., Lang P; Department of Pediatrics, Children's University Hospital, University of Tübingen, 72076 Tübingen, Germany., Künkele A; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.; Berliner Institut für Gesundheitsforschung (BIH), 10178 Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany., Eggert A; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.; Berliner Institut für Gesundheitsforschung (BIH), 10178 Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.; German Cancer Research Center Heidelberg (DKFZ), 69120 Heidelberg, Germany., Schulte JH; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.; Berliner Institut für Gesundheitsforschung (BIH), 10178 Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.; German Cancer Research Center Heidelberg (DKFZ), 69120 Heidelberg, Germany., Deubzer HE; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.; Berliner Institut für Gesundheitsforschung (BIH), 10178 Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.; German Cancer Research Center Heidelberg (DKFZ), 69120 Heidelberg, Germany.; Experimental and Clinical Research Center (ECRC), Charité-Universitätsmedizin Berlin and the Max-Delbrueck-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
Publikováno v:
Children (Basel, Switzerland) [Children (Basel)] 2020 Oct 28; Vol. 7 (11). Date of Electronic Publication: 2020 Oct 28.
Autor:
Andersch L; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany., Radke J; Department of Neuropathology, Charitéplatz 1, Charité, Universitätsmedizin Berlin, 10117, Berlin, Germany.; Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), Invalidenstr. 80, 10115, Berlin, Germany., Klaus A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany., Schwiebert S; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany., Winkler A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany., Schumann E; Department of Neuropathology, Charitéplatz 1, Charité, Universitätsmedizin Berlin, 10117, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), Invalidenstr. 80, 10115, Berlin, Germany., Grunewald L; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany., Zirngibl F; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.; Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany., Flemmig C; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.; Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany., Jensen MC; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.; Seattle Children's Research Institute, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Bioengineering, University of Washington, Seattle, WA, USA., Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany., Joussen A; Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Hindenburgdamm 30, 12200, Berlin, Germany., Henssen A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.; Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany., Eggert A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.; Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), Invalidenstr. 80, 10115, Berlin, Germany.; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Schulte JH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), Invalidenstr. 80, 10115, Berlin, Germany.; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Künkele A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany. Annette.Kuenkele@charite.de.; Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany. Annette.Kuenkele@charite.de.; German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), Invalidenstr. 80, 10115, Berlin, Germany. Annette.Kuenkele@charite.de.
Publikováno v:
BMC cancer [BMC Cancer] 2019 Sep 09; Vol. 19 (1), pp. 895. Date of Electronic Publication: 2019 Sep 09.
Autor:
Sabary, Gul Shah1 gul_khost@hotmail.com, Ključnikov, Aleksandr2
Publikováno v:
Equilibrium (1689-765X). Jun2023, Vol. 18 Issue 2, p491-522. 32p.
Publikováno v:
American Journal of Physiology: Cell Physiology; Aug2024, Vol. 327 Issue 2, pC362-C371, 10p
Autor:
Kulczycka, Marika1 (AUTHOR), Derlatka, Kamila1 (AUTHOR), Tasior, Justyna1 (AUTHOR), Lejman, Monika2 (AUTHOR), Zawitkowska, Joanna3 (AUTHOR) joannazawitkowska@umlub.pl
Publikováno v:
Journal of Clinical Medicine. Mar2023, Vol. 12 Issue 6, p2326. 19p.